Granulocyte macrophage-colony stimulating factor (GM-CSF) induced severe atypical rash in a patient of non-hodgkin's lymphoma
Granulocyte-macrophage colony-stimulating factor (GM-CSF) infusion has been reported with the development of transient maculopapular rash with spontaneous resolution. A 54-year-old Indian female developed intense erythematous generalised rash involving the face, trunk, extremities, palms and soles f...
Saved in:
Main Authors: | Gautam Kumar Singh (Author), Anuj Bhatnagar (Author), Debdeep Mitra (Author), Pooja Sharma (Author), Abhay Singh (Author), Barnali Mitra (Author) |
---|---|
Format: | Book |
Published: |
Wolters Kluwer Medknow Publications,
2022-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Directs effects of granulocyte-macrophage colony stimulating factor (GM-CSF) on adaptive immunogenesis
by: Victor Ivanovich Seledtsov, et al.
Published: (2019) -
Correspondence to: "A meta-analysis of granulocyte-macrophage colony-stimulating factor (GM-CSF) antibody treatment for COVID-19 patients."
by: Pankaj Bansal, et al.
Published: (2021) -
RETRACTED: A meta-analysis of granulocyte-macrophage colony-stimulating factor (GM-CSF) antibody treatment for COVID-19 patients
by: Jin-Tao Guan, et al.
Published: (2021) -
Granulocyte Macrophage-Colony Stimulating Factor (GM-CSF) Downregulates the Expression of Protumor Factors Cyclooxygenase-2 and Inducible Nitric Oxide Synthase in a GM-CSF Receptor-Independent Manner in Cervical Cancer Cells
by: Nanyan Jiang, et al.
Published: (2015) -
RETRACTION NOTICE: A meta-analysis of granulocyte-macrophage colony-stimulating factor (GM-CSF) antibody treatment for COVID-19 patients
Published: (2021)